Observational studyHealth and quality of life outcomes2026
Health-related quality of life and six-month hospitalization in older outpatients with heart failure with reduced ejection fraction: a prospective observational study.
Observational study in Health and quality of life outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHealth-related quality of life (HRQoL) is an important component of heart failure (HF) management but remains insufficiently characterized among older outpatients in low- and middle-income countries. The primary objective of this study was to determine the prevalence of impaired HRQoL in older Vietnamese outpatients with heart failure with reduced ejection fraction (HFrEF). The secondary objectives were to identify factors associated with impaired HRQoL and to examine factors associated with six-month HF hospitalization.
methodsWe conducted a prospective observational study between August 2024 and June 2025 among outpatients aged ≥ 60 years with confirmed HFrEF at two specialized HF clinics. HRQoL was assessed using the Kansas City Cardiomyopathy Questionnaire-23 (KCCQ-23), with impaired HRQoL defined as a score < 50. Participants were followed for six months for first HF hospitalization. Multivariable logistic regression was used to assess factors associated with impaired HRQoL, and Cox proportional hazards models were applied to evaluate factors associated with hospitalization.
resultsAmong 310 patients (median age 71 years), 48 (15.5%) had impaired HRQoL at baseline. Depression (odds ratio [OR] 4.12, 95% confidence interval [CI] 1.70–9.97; P = 0.002) and New York Heart Association (NYHA) class III (OR 6.55, 95% CI 3.01–13.9; P < 0.001) were independently associated with impaired HRQoL. During follow-up, 92 patients (29.7%) experienced a first HF hospitalization, of whom 32 (34.8%) had impaired HRQoL at baseline. Age ≥ 75 years (hazard ratio [HR] 1.93, 95% CI 1.22–3.06; P = 0.005), limitations in instrumental activities of daily living (HR 2.34, 95% CI 1.16–4.73; P = 0.018), and impaired HRQoL (HR 2.10, 95% CI 1.26–3.51; P = 0.004) were independently associated with a higher risk of hospitalization. Receipt of quadruple therapy was associated with a lower risk (HR 0.63, 95% CI 0.40–0.99; P = 0.047).
conclusionsIn older outpatients with HFrEF, impaired HRQoL was observed in approximately one-sixth of patients and was associated with depression and NYHA class III. Over six months, impaired HRQoL, advanced age, and limitations in instrumental activities of daily living were associated with an increased risk of HF hospitalization, whereas receipt of quadruple therapy was associated with a reduced risk. CLINICAL TRIAL NUMBER: This study was not registered as a clinical trial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.